Literature DB >> 15166685

Comparison of lorazepam and zopiclone for insomnia in patients with stroke and brain injury: a randomized, crossover, double-blinded trial.

Rodney S Li Pi Shan1, Nigel L Ashworth.   

Abstract

OBJECTIVES: To determine if lorazepam or zopiclone is more effective in providing a restful night of sleep and to assess the effects of these medications on cognition.
DESIGN: A randomized, double-blinded, crossover trial was performed at a tertiary care rehabilitation inpatient unit in a teaching hospital. A total of 18 brain-injured and stroke patients, aged 20-78 yrs, were administered lorazepam, 0.5-1.0 mg, orally at bedtime as needed for 7 days and zopiclone, 3.75-7.5 mg, orally at bedtime as needed for 7 days. Total sleep time and characteristics of sleep were measured. Effects on cognition were also measured using the Folstein Mini Mental Status Exam.
RESULTS: There was no difference in average sleep duration or in subjective measures of sleep. Cognition as assessed by the Mini Mental Status Exam revealed no difference in the zopiclone arm compared with the lorazepam arm.
CONCLUSION: Zopiclone is equally effective as lorazepam in the treatment of insomnia in stroke and brain-injured patients.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15166685     DOI: 10.1097/00002060-200406000-00003

Source DB:  PubMed          Journal:  Am J Phys Med Rehabil        ISSN: 0894-9115            Impact factor:   2.159


  13 in total

Review 1.  Sleep Disturbance After TBI.

Authors:  Surendra Barshikar; Kathleen R Bell
Journal:  Curr Neurol Neurosci Rep       Date:  2017-09-20       Impact factor: 5.081

Review 2.  Sleep-Wake Disturbances After Traumatic Brain Injury: Synthesis of Human and Animal Studies.

Authors:  Danielle K Sandsmark; Jonathan E Elliott; Miranda M Lim
Journal:  Sleep       Date:  2017-05-01       Impact factor: 5.849

3.  Management of sleep disorders in stroke.

Authors:  Kyoung Bin Im; Scott Strader; Mark Eric Dyken
Journal:  Curr Treat Options Neurol       Date:  2010-09       Impact factor: 3.598

Review 4.  The pharmacologic management of insomnia in patients with HIV.

Authors:  Toma S Omonuwa; Harold W Goforth; Xavier Preud'homme; Andrew D Krystal
Journal:  J Clin Sleep Med       Date:  2009-06-15       Impact factor: 4.062

Review 5.  Use of non-benzodiazepine hypnotics in the elderly: are all agents the same?

Authors:  Christian Dolder; Michael Nelson; Jonathan McKinsey
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

6.  Association Between the Use of Non-benzodiazepine Hypnotics and Cognitive Outcomes: A Systematic Review.

Authors:  Christopher N Kaufmann; Alison A Moore; Mark W Bondi; James D Murphy; Atul Malhotra; Laura A Hart
Journal:  Curr Sleep Med Rep       Date:  2020-01-28

7.  Evaluating the impact of treatment for sleep/wake disorders on recovery of cognition and communication in adults with chronic TBI.

Authors:  Catherine Wiseman-Hakes; Brian Murray; Rahim Moineddin; Elizabeth Rochon; Nora Cullen; Judith Gargaro; Angela Colantonio
Journal:  Brain Inj       Date:  2013-09-26       Impact factor: 2.311

Review 8.  Pharmacological interventions to improve sleep in hospitalised adults: a systematic review.

Authors:  Salmaan Kanji; Alexandru Mera; Brian Hutton; Lisa Burry; Erin Rosenberg; Erika MacDonald; Vanessa Luks
Journal:  BMJ Open       Date:  2016-07-29       Impact factor: 2.692

Review 9.  Traumatic brain injury-induced sleep disorders.

Authors:  Mari Viola-Saltzman; Camelia Musleh
Journal:  Neuropsychiatr Dis Treat       Date:  2016-02-15       Impact factor: 2.570

10.  Efficacy of melatonin for sleep disturbance following traumatic brain injury: a randomised controlled trial.

Authors:  Natalie A Grima; Shantha M W Rajaratnam; Darren Mansfield; Tracey L Sletten; Gershon Spitz; Jennie L Ponsford
Journal:  BMC Med       Date:  2018-01-19       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.